Adagene Statistics
Total Valuation
Adagene has a market cap or net worth of $269.92 million. The enterprise value is $148.10 million.
| Market Cap | 269.92M |
| Enterprise Value | 148.10M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, before market open.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Adagene has 67.14 million shares outstanding. The number of shares has increased by 11.73% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 67.14M |
| Shares Change (YoY) | +11.73% |
| Shares Change (QoQ) | +19.71% |
| Owned by Insiders (%) | 10.00% |
| Owned by Institutions (%) | 39.12% |
| Float | 42.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 29.05 |
| Forward PS | n/a |
| PB Ratio | 3.02 |
| P/TBV Ratio | 3.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.02, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.02 |
| Quick Ratio | 4.86 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -78.36 |
Financial Efficiency
Return on equity (ROE) is -28.50% and return on invested capital (ROIC) is -17.80%.
| Return on Equity (ROE) | -28.50% |
| Return on Assets (ROA) | -13.95% |
| Return on Invested Capital (ROIC) | -17.80% |
| Return on Capital Employed (ROCE) | -20.83% |
| Weighted Average Cost of Capital (WACC) | 7.32% |
| Revenue Per Employee | $72,584 |
| Profits Per Employee | -$160,242 |
| Employee Count | 128 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -366,334 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +93.72% in the last 52 weeks. The beta is 0.57, so Adagene's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +93.72% |
| 50-Day Moving Average | 3.85 |
| 200-Day Moving Average | 3.12 |
| Relative Strength Index (RSI) | 55.10 |
| Average Volume (20 Days) | 292,459 |
Short Selling Information
The latest short interest is 2.29 million, so 4.08% of the outstanding shares have been sold short.
| Short Interest | 2.29M |
| Short Previous Month | 2.19M |
| Short % of Shares Out | 4.08% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.27 |
Income Statement
In the last 12 months, Adagene had revenue of $9.29 million and -$20.51 million in losses. Loss per share was -$0.39.
| Revenue | 9.29M |
| Gross Profit | 9.29M |
| Operating Income | -22.34M |
| Pretax Income | -20.88M |
| Net Income | -20.51M |
| EBITDA | -21.95M |
| EBIT | -22.34M |
| Loss Per Share | -$0.39 |
Balance Sheet
The company has $127.91 million in cash and $6.09 million in debt, with a net cash position of $121.82 million or $1.81 per share.
| Cash & Cash Equivalents | 127.91M |
| Total Debt | 6.09M |
| Net Cash | 121.82M |
| Net Cash Per Share | $1.81 |
| Equity (Book Value) | 106.00M |
| Book Value Per Share | 1.33 |
| Working Capital | 106.05M |
Cash Flow
In the last 12 months, operating cash flow was -$19.25 million and capital expenditures -$170,783, giving a free cash flow of -$19.42 million.
| Operating Cash Flow | -19.25M |
| Capital Expenditures | -170,783 |
| Depreciation & Amortization | 384,223 |
| Net Borrowing | -1.21M |
| Free Cash Flow | -19.42M |
| FCF Per Share | -$0.29 |
Margins
Gross margin is 100.00%, with operating and profit margins of -240.42% and -220.77%.
| Gross Margin | 100.00% |
| Operating Margin | -240.42% |
| Pretax Margin | -224.71% |
| Profit Margin | -220.77% |
| EBITDA Margin | -236.28% |
| EBIT Margin | -240.42% |
| FCF Margin | n/a |
Dividends & Yields
Adagene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.73% |
| Shareholder Yield | -11.73% |
| Earnings Yield | -7.60% |
| FCF Yield | -7.19% |
Analyst Forecast
The average price target for Adagene is $10.74, which is 167.83% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.74 |
| Price Target Difference | 167.83% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | -0.15% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Adagene has an Altman Z-Score of -0.08 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.08 |
| Piotroski F-Score | 3 |